Flucelvax Trivalent 2024-2025 is an injectable vaccine that protects towards three strains of the influenza virus. It’s accepted to be used in folks 6 months of age and older.
Flucelvax Trivalent 2024-2025 is made utilizing a cell culture-based manufacturing methodology. Which means the vaccine is produced in a managed atmosphere utilizing mammalian cells. This methodology is extra environment friendly and cheaper than conventional egg-based manufacturing strategies.
Flucelvax Trivalent 2024-2025 has been proven to be protected and efficient in medical trials. It’s well-tolerated, with the most typical unwanted effects being injection website ache, redness, and swelling.
